세포배양 배지 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Cell Culture Media Market Summary

The global cell culture media market size was estimated at USD 4.31 billion in 2024 and is projected to reach USD 12.80 billion by 2033, growing at a CAGR of 13.20% from 2025 to 2033. Cell culture media is generally a gel or liquid, and it includes compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals.

Growth In Stem Cell Research

Stem cell therapy has emerged as a promising frontier in scientific research, offering transformative potential in regenerative medicine. Stem cells play a crucial role in restoring damaged tissues and organs and provide valuable insights into the intricate processes of human development. As a result, there is a growing interest in improving stem cell culture methods to support basic research into stem cell biology and enhance their therapeutic potential. The increasing demand for high-quality, reliable cell culture media tailored specifically for stem cells reflects this trend, with scientists and clinicians seeking more efficient and defined culture environments to optimize stem cell expansion and differentiation.

To meet this rising demand, several key manufacturers have introduced innovative products to advance stem cell research. For instance, in July 2024, Bioserve India launched a range of new stem cell products, including cell culture solutions and reprogramming tools, to support scientific research and drug development in the country. Similarly, in December 2024, BioCentriq, a leading cell therapy CDMO, secured a long-term lease for a new headquarters in Princeton, New Jersey, with a USD 12 million investment dedicated to enhancing its development, manufacturing, and quality control services in cell therapy. These strategic developments reflect the growing momentum in the stem cell field and highlight the increasing importance of advanced cell culture media in supporting research and clinical applications.

Research Emerging Cell Culture Technologies for Cell-Based Vaccines

Cell culture-based viral vaccines have become a critical component of global immunization strategies, offering a safer and more efficient method for producing vaccines than traditional egg-based approaches. The continuous development of cell culture substrates allows for the reliable and scalable production of vaccines, meeting rising global demand while adhering to stringent safety and regulatory requirements. According to the CDC, from 2020 to 2021, the viruses supplied to manufacturers for flu vaccine production were cell-derived rather than egg-derived, due to the potential for egg-based cultivation to introduce antigenic changes. Such changes can reduce vaccine effectiveness by creating mismatches between vaccine strains and circulating viruses. Moreover, the FDA's approval of cell-based candidate vaccine viruses (CVVs) has strengthened the pathway for more consistent and potentially more effective flu vaccines.

The utility of cell culture technology extends beyond influenza to include vaccines for diseases such as smallpox, rotavirus, rubella, hepatitis, chickenpox, and polio. Notably, in December 2024, Mesoblast received FDA approval for Ryoncil (remestemcel-L), a mesenchymal stromal cell (MSC) therapy, for treating steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients, marking the first and only MSC therapy approved in the U.S. Ryoncil is also under development for other inflammatory conditions, including biologic-resistant inflammatory bowel disease. The ongoing advancement in biological models, refinement of cell culture media, and reduced reliance on animal-derived components continue to fuel innovation in cell-based vaccine development.

Global Cell Culture Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture media market report based on product, application, type, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Serum-free Media
  • CHO Media
  • BHK Medium
  • Vero Medium
  • HEK 293 Media
  • Other Serum-free media
• Classical Media
• Stem Cell Culture Media
  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Other Stem Cells
• Immunology Media
  • T Cells
  • B Cells
  • Natural Killer (NK) Cells
  • Other Immune Cells
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Diagnostics
• Drug Screening and Development
• Tissue Engineering and Regenerative Medicine
  • Cell and Gene Therapy
  • Other Tissue Engineering and Regenerative Medicine Applications
• Other Applications
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Liquid Media
• Semi-solid and Solid Media
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Other End uses
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Type
  • 1.2.4. End use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Expansion of biosimilars and biologics
    • 3.3.1.2. Growth in stem cell research
    • 3.3.1.3. Emerging cell culture technologies for cell-based vaccines
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Ethical issues concerning the use of animal-derived products
    • 3.3.2.2. Stringent regulatory guidelines
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Cell Culture Media Market Product, Movement Analysis
• 4.3. Cell Culture Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Serum-free Media
  • 4.4.1. Serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. CHO Media
    • 4.4.2.1. CHO media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. HEK 293 media
    • 4.4.3.1. HEK 293 media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. BHK media
    • 4.4.4.1. BHK media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Vero medium
    • 4.4.5.1. Vero medium market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Other serum-free media
    • 4.4.6.1. Other serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Classical Media
  • 4.5.1. Classical media market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Stem Cell Culture Media
  • 4.6.1. stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Mesenchymal Stem Cells (MSCs)
    • 4.6.2.1. Mesenchymal Stem Cells (MSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Hematopoietic Stem Cells (HSCs)
    • 4.6.3.1. Hematopoietic Stem Cells (HSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Induced Pluripotent Stem Cells (iPSCs)
    • 4.6.4.1. Induced Pluripotent Stem Cells (iPSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.5. Other Stem Cells
    • 4.6.5.1. Other Stem Cells market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Immunology Media
  • 4.7.1. immunology media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. T Cells
    • 4.7.2.1. T Cells market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. B Cells
    • 4.7.3.1. B Cells market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. Natural Killer (NK) Cells
    • 4.7.4.1. Natural Killer (NK) Cells market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.5. Other Immune Cells
    • 4.7.5.1. Other Immune Cells market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.8. Chemically Defined Media
  • 4.8.1. Chemically defined media market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.9. Specialty Media
  • 4.9.1. Speciality media market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.10. Other Cell Culture Media
  • 4.10.1. Other cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Cell Culture Media Market Type, Movement Analysis
• 5.3. Cell Culture Media Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Liquid Media
  • 5.4.1. liquid media market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Semisolid & Solid Media
  • 5.5.1. semi-solid & solid media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Cell Culture Media Market Application, Movement Analysis
• 6.3. Cell Culture Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical Production
  • 6.4.1. Biopharmaceutical production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Monoclonal antibodies
    • 6.4.2.1. Monoclonal antibodies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Vaccines production
    • 6.4.3.1. Vaccines production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Other therapeutic proteins
    • 6.4.4.1. Other therapeutic proteins market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Diagnostics
  • 6.5.1. diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Drug Screening & Development
  • 6.6.1. drug screening & development market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Tissue Engineering & Regenerative Medicine
  • 6.7.1. tissue engineering & regenerative medicine market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Cell & gene therapy
  • 6.7.3. cell & gene therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. Other tissue engineering & regenerative medicine
    • 6.7.4.1. Other tissue engineering & regenerative medicine market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.8. Other Applications
  • 6.8.1. Other applications market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Cell Culture Media Market End Use, Movement Analysis
• 7.3. Cell Culture Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals & Diagnostic Laboratories
  • 7.5.1. hospitals & diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Research & Academic Institutes
  • 7.6.1. Research & academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Other End Use
  • 7.7.1. Other End use market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Type, Application, & End-Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico cell culture media market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway cell culture media market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.5. Singapore
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Singapore cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Australia cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Thailand cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.8. South Korea
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. South Korea cell culture media market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America cell culture media market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil cell culture media market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina cell culture media market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait cell culture media market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Sartorius AG
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Danaher
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Merck KGaA
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Thermo Fisher Scientific, Inc.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. FUJIFILM Corporation
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Lonza
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. BD
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. STEMCELL Technologies
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Cell Biologics, Inc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. PromoCell GmbH
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives